Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch
This article was originally published in The Tan Sheet
Executive Summary
Despite concerns raised by the Nonprescription Drug Advisory Committee in November, FDA approves Merck’s overactive bladder drug Oxytrol for Women for OTC use. The company plans a launch in the fall.